wehewehe
Hanaʻia kā mākou 4-Chloropyrrolidine CAS No. 3680-69-1 i nā kūlanaʻoihana kiʻekiʻe loa, e hōʻoiaʻiʻo ana i ka maʻemaʻe a me ke kūlike i kēlā me kēia hui.Ma ke ʻano he alakaʻi alakaʻi o nā kemika maikaʻi a me nā mea waena, haʻaheo mākou iā mākou iho i ka hāʻawi ʻana i kā mākou mea kūʻai aku i nā huahana maikaʻi loa i kūpono i kā lākou kikoʻī kikoʻī a me nā koi.
ʻO 4-Chloropyrrolidine kahi mea nui i ka synthesis o tofacitinib, i ʻike ʻia no kona pono e hōʻemi i ka ʻeha a me ka ʻeha e pili ana i nā maʻi autoimmune.Ma ka hoʻohanaʻana i kā mākou mau kikowaena kiʻekiʻe, hiki i nā mea hana lāʻau lapaʻau ke hana i ka tofacitinib a me nā mea'ē aʻe e pili ana me ka hilinaʻi, me kaʻike i ka maʻemaʻe a me ka hilinaʻi o kā mākou 4-chloropyrrolidine e kōkua i ka maikaʻi o ka huahana hope loa.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
![Vorolazan Intermediate 5 – (2-fluorophenyl) – 1 – [(pyridin-3-yl) sulfonyl] – 1H-pyrrol-3-formaldehyde CAS No. 881677-11-8](http://cdn.globalso.com/jdkhc/5-2-fluorophenyl-1-pyridin-3-yl-sulfonyl-1H-pyrrol-3-formaldehyde.jpg)
![10- (2-Chloropyrimidin-4-yl) -6,7,8,9-tetrahydropyridino [1,2-a] indole 2035090-53-8](http://cdn.globalso.com/jdkhc/10-2-Chloropyrimidin-4-yl-6789-tetrahydropyridino-12-a-indole.jpg)
![1- [3- (Acetoxy) phenyl] -2-bromoethanone 38396-89-3](http://cdn.globalso.com/jdkhc/1-3-Acetoxy-phenyl-2-bromoethanone.jpg)
